Do antiplatelet agents contribute to the development of perioperative spinal hematoma?
Urmey
W F
WF
Department of Anesthesiology, Hospital for Special Surgery, Cornell University Medical College, New York, New York 10021, USA.
Rowlingson
J
J
D000244:Adenosine Diphosphate / Q000037:antagonists & inhibitors; D000765:Anesthesia, Conduction / Q000009:adverse effects; D001241:Aspirin / Q000009:adverse effects; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects; D006406:Hematoma / Q000209:etiology*; D006629:Hirudins / Q000009:adverse effects; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D011480:Protease Inhibitors / Q000009:adverse effects; D013118:Spinal Cord Diseases / Q000209:etiology*; D013917:Thrombin / Q000037:antagonists & inhibitors; D013988:Ticlopidine / Q000009:adverse effects
D016861:Cyclooxygenase Inhibitors; D006629:Hirudins; D010975:Platelet Aggregation Inhibitors; D011480:Protease Inhibitors; D000244:Adenosine Diphosphate; D013917:Thrombin; D013988:Ticlopidine; D001241:Aspirin